Loading
Latest filing published 19 Jul 2023 for Idera Pharmaceuticals, INC., €5,111.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Pillar Invest Corp discloses dealings in Idera Pharmaceuticals, Inc. to SEC (Form 4). The record holds 3 filings, for trades running from 22 September 2022 to 12 July 2023.
On the open market, the record shows 1 purchase worth €35k and 1 sale worth €5,111. Purchases outweigh sales by €30k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 1 share grant. So far in 2023, the count stands at 1 purchase and 1 sale.
Most recently, on 19 July 2023, the filings show an open-market sale worth €5,111 in Idera Pharmaceuticals, Inc. The latest purchase dates back some time: it was published 1,193 days ago, on 19 July 2023. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 7 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations